SBS Announces Call for Papers Submission Deadline
News Mar 09, 2006
For the first time as Society for Biomolecular Sciences, the SBS Annual Conference & Exhibition, the premier scientific and showcase event in molecular discovery, brings together 2,000 professionals, offering an opportunity to learn more about the latest innovations, technologies, and research in the drug discovery sciences from all over the world.
Oral Abstract Submission Monday, April 3, 2006
Poster Abstract Submission Monday, June 26, 2006 (for inclusion in conference handbook)
Final date for presenting poster onsite - Friday, August 18, 2006
Deadlines are firm in order to meet publication schedules. All submissions must represent original research not previously presented.
All abstracts must be submitted electronically at website. Abstracts may not exceed 150 words and should be unformatted with no line breaks.
Specific formatting requirements can be found on the website. Upon submission, authors give SBS the right to publish abstracts in any format before, during or after the 2006 Conference & Exhibition.
SBS requires an active e-mail address for communication regarding abstract status.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019